GlassScriptPhysician profile
Lauren M Howdeshell
NPI 1093207243
$7,652.01
in general payments reported to CMS, 2019-2025
33 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,942 · 2022: $2,246 · 2023: $2,789 · 2024: $358 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,464.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,579.05 | 2021-2023 | Freestyle Libre 3 |
| Amgen INC. | $1,128.59 | 2021-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $1,066.01 | 2021-2024 | Rybelsus, Ozempic |
| Dexcom, INC. | $818.33 | 2021-2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $454.36 | 2021-2023 | |
| Medtronic, INC. | $337.09 | 2021-2023 | Minimed 780g |
| Regeneron Healthcare Solutions, INC. | $291.23 | 2024-2025 | Dupixent |
| Amarin Pharma, INC. | $251.84 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $189.86 | 2021-2023 | Signifor Lar, Isturisa |
| Renalytix Ai, INC. | $188.02 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Nestle Healthcare Nutrition INC. | $181.96 | 2021-2023 | |
| Ibsa Pharma INC. | $169.90 | 2021-2023 | Tirosint, Licart |
| Mannkind Corporation | $142.88 | 2023 | Afrezza |
| Ascendis Pharma Endocrinology INC | $135.52 | 2023 | |
| Corcept Therapeutics | $111.33 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuity Medical INC | $92.10 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Eusa Pharma (US) LLC | $77.26 | 2022 | |
| Embecta Corp. | $52.02 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Glaxosmithkline, LLC. | $51.46 | 2024-2025 | Nucala |
| Optinose US, INC. | $36.64 | 2024-2025 | |
| Smith+Nephew, INC. | $32.66 | 2023 | Regranex |
| Becton, Dickinson and Company | $32.54 | 2022 | |
| Amryt Pharma Holdings LTD | $24.99 | 2023 | Mycapssa |
| Cequr Corporation | $23.60 | 2023 | Cequr Simplicity |
| Xeris Pharmaceuticals, INC. | $23.42 | 2023 | Keveyis |
| Itamar Medical INC | $23.07 | 2024 | Watchpatone |
| Phadia US INC. | $21.52 | 2024 | Immunocap |
| Aimmune Therapeutics, INC. | $21.00 | 2024 | |
| Genzyme Corporation | $20.70 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.57 | 2022 | |
| Inspire Medical Systems, INC. | $18.57 | 2024 | Inspire |
| Alexion Pharmaceuticals, INC. | $17.24 | 2023 | Strensiq |
| Novartis Pharmaceuticals Corporation | $16.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Howdeshell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.